Standout Papers

Outcomes in hypertensive patients at ... 1972 2026 1990 2008 1.8k
  1. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial (2004)
    Stevo Julius, Sverre E. Kjeldsen et al. The Lancet
  2. Hypertension : pathophysiology, diagnosis, and management (1995)
    John H. Laragh, Barry M. Brenner Raven Press eBooks
  3. Essential Hypertension: Renin and Aldosterone, Heart Attack and Stroke (1972)
    Hans R. Brunner, John H. Laragh et al. New England Journal of Medicine
  4. Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk (1995)
    Giovanni de Simone, Richard B. Devereux et al. Journal of the American College of Cardiology
  5. Standardization of M-mode echocardiographic left ventricular anatomic measurements (1984)
    Richard B. Devereux, Elizabeth M. Lutas et al. Journal of the American College of Cardiology
  6. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. (1986)
    Robert Cody, Steven A. Atlas et al. Journal of Clinical Investigation
  7. Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with Hypertension (1991)
    M. H. Alderman, Shantha Madhavan et al. New England Journal of Medicine
  8. Propranolol Inhibition of Renin Secretion (1972)
    Fritz R. Bühler, John H. Laragh et al. New England Journal of Medicine
  9. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. (1983)
    Richard B. Devereux, Thomas G. Pickering et al. Circulation
  10. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension (1994)
    Giovanni de Simone, Richard B. Devereux et al. Journal of the American College of Cardiology
  11. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease (1972)
    John H. Laragh, Leslie Baer et al. The American Journal of Medicine
  12. Hypotensive Agents and Pressor Substances (1960)
    John H. Laragh JAMA
  13. Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profiles (1973)
    John H. Laragh The American Journal of Medicine
  14. Hyperuricemia in Primary and Renal Hypertension (1966)
    Paul J. Cannon, William B. Stason et al. New England Journal of Medicine

Immediate Impact

12 by Nobel laureates 26 from Science/Nature 69 standout
Sub-graph 1 of 19

Citing Papers

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
2020 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
2 intermediate papers

Works of John H. Laragh being referenced

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial
2004
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout

Author Peers

Author Last Decade Papers Cites
John H. Laragh 21170 9352 5999 472 35.0k
Suzanne Oparil 23662 10696 4440 705 39.8k
Roland E. Schmieder 19485 7526 2815 618 28.4k
Luís M. Ruilope 19422 9780 3376 754 29.8k
Alberto Zanchetti 33634 10242 3163 819 44.3k
Ernesto L. Schiffrin 18664 10224 3412 562 38.3k
Robert M. Carey 13875 11795 2737 377 26.6k
Michel E. Safar 30848 5562 6691 619 39.0k
James R. Sowers 15126 14251 2338 681 41.2k
Friedrich C. Luft 16685 8911 5347 1.0k 49.6k
Rhian M. Touyz 12351 7362 2648 512 35.9k

All Works

Loading papers...

Rankless by CCL
2026